CVS to pay $315 million to settle Justice Department opioid prescription lawsuit

Right · 2CVS Pharmacy Inc. and various subsidiaries agreed on Tuesday 13 October 2026 to pay $315 million to settle a Justice Department lawsuit over opioid prescriptions. 1 2 Right · 1The suit, brought in 2024, alleged the chain illegally dispensed opioids and other controlled substances that were medically unnecessary, and that it profited "at the expense of public health and safety". 1 Right · 1According to the Washington Examiner, the case was filed on behalf of former CVS employee Hillary Estright and alleged violations of the Controlled Substances Act and the False Claims Act, including that CVS then sought reimbursement from federal healthcare programs for many of the prescriptions. 2

Right · 1The government alleged CVS filled prescriptions for excessive quantities of opioids, filled prescriptions early, sold "trinity" combinations of an opioid, a benzodiazepine and a muscle relaxant, and filled prescriptions from "pill mill" providers despite clear warning signs. 2 Right · 1It also alleged that performance metrics, incentive pay and staffing policies put profits ahead of patient safety, that CVS did not employ enough pharmacists, and that policies kept pharmacists from warning colleagues about problematic prescribers. 2 Right · 2Associate Attorney General Stanley Woodward called the settlement a "significant milestone in the Justice Department’s efforts to combat the opioid epidemic". 1 2

Right · 1Assistant Attorney General Brett Shumate said the agreement requires CVS to add safeguards so controlled-substance prescriptions are dispensed only when medically appropriate, including proactive monitoring of opioid prescribing patterns. 2 Right · 2CVS said it strongly disagrees with the claims and that the settlement admits no wrongdoing, and a spokesperson said its more than 27,000 pharmacists are highly trained in the safe and appropriate use of medications. 1 2